University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT02573766
The goal of this clinical research study is to learn if using a type of non-invasive therapy called neurofeedback training can help teach patients with peripheral neuropathy how to change their own brain waves to lower their perception of neuropathy and help improve their overall quality of life.
Neurofeedback training is a type of therapy that uses an electroencephalograph (EEG) and a computer software program to measure brain wave activity.
This is an investigational study. The equipment used for neurofeedback training is FDA approved and commercially available. Using neurofeedback equipment to teach patients ways to modify their own brain waves to lower the perception of symptoms and improve quality of life is considered investigational.
Up to 99 participants over the age of 18 will take part in this study. All will be enrolled at MD Anderson.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Female
Interventional
Not applicable
Houston, Texas, 77030, United States
Baseline Tests:
If you agree to take part in this study, you will have the following baseline tests:
Study Groups:
After completing the baseline tests, you will be randomly assigned (as in the roll of a dice) to 1 of 3 study groups. This is done because no one knows if one study group is better, the same, or worse than the other group.
If you are assigned to Groups 1 or 2, you will not be told if you are receiving traditional neurofeedback training or sham training.
Neurofeedback Training (Groups 1 and 2):
You will have at least 2 neurofeedback training sessions each week for up to 10 weeks (20 training sessions total). The training sessions may take place on any 2 days of the week and may be up to 5 times a week, if you are interested in training more quickly. The study doctor will discuss the option of training faster with you.
Each neurofeedback training session should take about 1 hour to complete.
During each session, you will have an EEG while you sit quietly, relax, and watch a computer screen. The screen will be blank at first and then a series of pictures will appear. The pictures will change as your brainwaves change. You may also be shown pictures of flowers, bridges, mountains, and so on. You may be asked to play small games, for example a Pac-Man type game in which a small character moves around a maze. You will be able to choose to either view pictures or play a game.
When researchers see that your brain waves change in the way they are looking for, you will be "rewarded." When you are rewarded you will see a pretty picture on screen and you will hear a beep.
A neurotherapist will be present during each session to make sure you do not fall asleep and that you are relaxed during the procedure.
At each neurofeedback training session, you will also be asked to rate your neuropathic symptoms on a scale of 0-10 before you begin the neurofeedback training and again after the session is complete. This should only take a few minutes.
Length of Participation:
Your active participation on this study will be over after follow-up. If you are in Groups 2 or 3, you may be able to stay on study for an additional 4 months if you agree to Optional Procedure #1 (described below).
Follow-Up (All groups):
Within 1 week after your last neurofeedback training session and again about 1 month later:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Neurofeedback Group + Sham Neurofeedback Group: Participants participate in sessions for a minimum of 2 treatments a week for a maximum of 10 weeks for a total of 20 sessions.
Participants undergo an EEG at baseline, during each neurofeedback session, within 7 days of the conclusion of treatment, and again in one month.
Standard of care group receives EEG at baseline, 1 week after neurofeedback group completes sessions, and again in one month.
Other names: EEG
Participants in neurofeedback groups asked to rate their pain on a scale of 0 (no pain) to 10 (the worst pain) prior to each session of neurofeedback, and again at the conclusion of the session.
Other names: Questionnaire, Survey
Seven questionnaires regarding symptoms and quality of life completed at baseline, 1 week after neurofeedback sessions, and again in one month.
Other names: Surveys
Time frame: 4 months
Pain Quality Assessment Scale (PQAS) used to evaluate responses in each group.
Time frame: 4 months
Changes in neuromodulation assessed using a quantitative EEG.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04917796
Agnosia, CIPN - Chemotherapy-Induced Peripheral Neuropathy
Boston, Massachusetts, United States
View Trial DetailsNCT03905668
Confusion, Delirium
Gainesville, Florida, United States
View Trial DetailsNCT04385082
Abuse, Drug, Chemically-Induced Disorders
Los Angeles, California, United States
View Trial DetailsNCT07570069
Neurologic Manifestations, Pain
Salt Lake City, Utah, United States
View Trial Details